IL166478A0 - Bicifadine formulation - Google Patents
Bicifadine formulationInfo
- Publication number
- IL166478A0 IL166478A0 IL16647805A IL16647805A IL166478A0 IL 166478 A0 IL166478 A0 IL 166478A0 IL 16647805 A IL16647805 A IL 16647805A IL 16647805 A IL16647805 A IL 16647805A IL 166478 A0 IL166478 A0 IL 166478A0
- Authority
- IL
- Israel
- Prior art keywords
- bicifadine
- formulation
- bicifadine formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39985202P | 2002-07-31 | 2002-07-31 | |
| PCT/IB2003/003700 WO2004012722A2 (en) | 2002-07-31 | 2003-07-21 | Bicifadine formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166478A0 true IL166478A0 (en) | 2006-01-15 |
Family
ID=31495768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16647805A IL166478A0 (en) | 2002-07-31 | 2005-01-25 | Bicifadine formulation |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040127541A1 (xx) |
| EP (1) | EP1539148A2 (xx) |
| JP (1) | JP2005537295A (xx) |
| KR (1) | KR20050035250A (xx) |
| CN (1) | CN1684681A (xx) |
| AU (1) | AU2003253198A1 (xx) |
| CA (1) | CA2493593A1 (xx) |
| IL (1) | IL166478A0 (xx) |
| MX (1) | MXPA05001127A (xx) |
| NO (1) | NO20050771L (xx) |
| NZ (1) | NZ538519A (xx) |
| PL (1) | PL375086A1 (xx) |
| RU (1) | RU2005105302A (xx) |
| WO (1) | WO2004012722A2 (xx) |
| ZA (1) | ZA200501541B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
| US20080081834A1 (en) | 2002-07-31 | 2008-04-03 | Lippa Arnold S | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| KR20090033410A (ko) * | 2004-06-17 | 2009-04-02 | 메르츠 파마 게엠베하 운트 코. 카가아 | 메만타인 또는 네라멕산의 직접 압축으로 제조된 마실수 있는 즉시 방출형 제제 |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| US20060100263A1 (en) * | 2004-11-05 | 2006-05-11 | Anthony Basile | Antipyretic compositions and methods |
| EP2719384B1 (en) | 2005-07-27 | 2018-08-08 | Otsuka America Pharmaceutical, Inc. | Novel 1-naphthyl-3-azabicyclo[3.1.0]hexanes:preparation and use to treat neuropsychiatric disorders |
| US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| US8138377B2 (en) * | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| US20080269348A1 (en) * | 2006-11-07 | 2008-10-30 | Phil Skolnick | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| EP2167083B1 (en) * | 2007-06-06 | 2015-10-28 | Euthymics Bioscience, Inc. | 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196120A (en) * | 1975-07-31 | 1980-04-01 | American Cyanamid Company | Azabicyclohexanes, method of use and preparation of the same |
| US4231935A (en) * | 1975-07-31 | 1980-11-04 | American Cyanamid Company | 1-Phenyl-3-azabicyclo[3.1.0]hexanes |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
-
2003
- 2003-07-17 US US10/621,435 patent/US20040127541A1/en not_active Abandoned
- 2003-07-21 KR KR1020057001706A patent/KR20050035250A/ko not_active Application Discontinuation
- 2003-07-21 CN CNA038229471A patent/CN1684681A/zh active Pending
- 2003-07-21 NZ NZ538519A patent/NZ538519A/en unknown
- 2003-07-21 JP JP2004525706A patent/JP2005537295A/ja not_active Withdrawn
- 2003-07-21 RU RU2005105302/14A patent/RU2005105302A/ru not_active Application Discontinuation
- 2003-07-21 EP EP03766584A patent/EP1539148A2/en not_active Withdrawn
- 2003-07-21 WO PCT/IB2003/003700 patent/WO2004012722A2/en active Application Filing
- 2003-07-21 PL PL03375086A patent/PL375086A1/xx not_active Application Discontinuation
- 2003-07-21 MX MXPA05001127A patent/MXPA05001127A/es unknown
- 2003-07-21 CA CA002493593A patent/CA2493593A1/en not_active Abandoned
- 2003-07-21 AU AU2003253198A patent/AU2003253198A1/en not_active Abandoned
-
2005
- 2005-01-25 IL IL16647805A patent/IL166478A0/xx unknown
- 2005-02-11 NO NO20050771A patent/NO20050771L/no not_active Application Discontinuation
- 2005-02-22 ZA ZA200501541A patent/ZA200501541B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL375086A1 (en) | 2005-11-14 |
| WO2004012722A3 (en) | 2004-04-08 |
| CN1684681A (zh) | 2005-10-19 |
| CA2493593A1 (en) | 2004-02-12 |
| US20040127541A1 (en) | 2004-07-01 |
| NZ538519A (en) | 2008-05-30 |
| WO2004012722A2 (en) | 2004-02-12 |
| EP1539148A2 (en) | 2005-06-15 |
| KR20050035250A (ko) | 2005-04-15 |
| MXPA05001127A (es) | 2005-10-18 |
| AU2003253198A1 (en) | 2004-02-23 |
| NO20050771L (no) | 2005-03-31 |
| JP2005537295A (ja) | 2005-12-08 |
| RU2005105302A (ru) | 2005-08-27 |
| ZA200501541B (en) | 2006-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166478A0 (en) | Bicifadine formulation | |
| AU2003225031A1 (en) | Eptfe-reinforced perfluoroelastomers | |
| GB0319874D0 (en) | Novel formulation | |
| GB0207438D0 (en) | Formulation | |
| AU2003226487A8 (en) | Formulation | |
| HUP0303948A2 (hu) | Szájban diszpergálódó szilárd gyógyszerforma | |
| GB0318448D0 (en) | Formulation | |
| AU2003217110A1 (en) | Novel formulation | |
| GB0312195D0 (en) | Formulation | |
| GB0218194D0 (en) | Solid formulations | |
| GB0320522D0 (en) | Formulation | |
| EP1549291A4 (en) | INJECTION FORMULATION | |
| GB0303876D0 (en) | Formulation | |
| GB0214147D0 (en) | Formulations | |
| AU155791S (en) | Stand | |
| GB0216968D0 (en) | Monitor | |
| EP1507542A4 (en) | ANTICANCER PREPARATION | |
| GB2387348B (en) | Flat-folding stand | |
| GB0225040D0 (en) | Formulation | |
| GB0217078D0 (en) | Formulation | |
| GB0215589D0 (en) | Formulation | |
| GB0215591D0 (en) | Formulation | |
| AU2002953460A0 (en) | Dental formulation | |
| AU2003238900A8 (en) | Pharmaceutical formulation | |
| AU2003260462A8 (en) | Rapid application integration |